Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

Article Abstract:

Patients who take high doses of inhaled corticosteroids may have an increased risk of glaucoma or ocular hypertension. Inhaled corticosteroids are often used to treat asthma. Researchers compared the use of inhaled corticosteroids in 9,793 patients diagnosed with glaucoma or ocular hypertension and 38,325 people diagnosed with other eye diseases. Those who used high doses of inhaled corticosteroids for more than 3 months had a 44% increased risk of glaucoma or ocular hypertension. These patients should have regular eye examinations.

Author: Suissa, Samy, LeLorier, Jacques, Boivin, Jean-Francois, Garbe, Edeltraut
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1997
Health aspects, Corticosteroids, Adrenocortical hormones, Open-angle glaucoma, Intranasal medication, Nasal sprays

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Valvular heart disease and the use of dopamine agonists for Parkinson's disease

Article Abstract:

An echocardiographic prevalence study was performed in 155 patients taking dopamine agonists for Parkinson's disease and 90 control subjects. The findings reveal that the frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline but not in patients taking non-ergot-derived dopamine agonists as compared with control subjects.

Author: Zanettini, Renzo, Antonini, Angelo, Gatto, Gemma, Gentile, Rosa, Tesei, Silvana, Pezzoli, Gianni
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
United States, Drug therapy, Parkinson's disease, Parkinson disease

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Dopamine agonists and the risk of cardiac-valve regurgitation

Article Abstract:

A cohort study was conducted with a nested case-control analysis to investigate the risk of newly diagnosed cardiac-valve regurgitation associated with the use of different dopamine agonists. The findings reveal that the use of the dopamine agonist's pergolide and cabergoline was associated with an increased risk of newly diagnosed cardiac-valve regurgitation.

Author: Suissa, Samy, Schade, Rene, Andersohn, Frank, Haverkamp, Wilhelm, Garbe, Edeltraut
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Quebec

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Complications and side effects, Risk factors, Dosage and administration, Heart valve diseases, Dopamine, Dopamine agonists
Similar abstracts:
  • Abstracts: Extended work shifts and the risk of motor vehicle crashes among interns. Extended work duration and the risk of self-reported percutaneous injuries in interns
  • Abstracts: Racial variation in the use of coronary-revascularization procedures: are the differences real? Do they matter?
  • Abstracts: Stepping out of your comfort zone is very rewarding. Risk of pressure damage for women using maternity services
  • Abstracts: Cardiac monitoring. Chest examination: Part 1- Chest palpation
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.